Implandata announced the successful implantation of its EyeMate intraocular pressure sensor for the first time in a patient undergoing keratoprosthesis surgery in Europe.
The telemetrically powered EyeMate intraocular pressure sensor implant allows physicians to non-invasively measure and closely monitor and control IOP in keratoprosthesis patients.
The implantation was a part of the ongoing ARGOS-KP01 pre-market study conducted by Implandata to generate clinical data for potential CE Mark approval.
More articles on ASC turnarounds:
6 statistics on ASC assets
7 things for ASC leaders to know for Thursday
Dr. Adam Mezoff: How to successfully juggle physician leadership roles